GeneNews' Revenues Flat as It Cuts Loss | GenomeWeb

NEW YORK (GenomeWeb News) – GeneNews last night reported that its first-quarter revenues were flat year over year, while the firm cut its net loss 23 percent.

The Toronto-based genetic test maker brought in revenues of C$300,000 (US$255,000) for the three months ended March 31, the same amount it reported for the first quarter of 2008. GeneNews said that revenues for the quarter were derived from sales of its ColonSentry test for assessing an individual's risk for colorectal cancer, as well as a technology access fee it received from an unnamed company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.